David Hutton

Bausch + Lomb has enrolled 599 participants in the first of two Phase 3 studies evaluating perfluorohexyloctane as a first-in-class investigational drug to treat the signs and symptoms of dry eye disease associated with meibomian gland dysfunction.

A device developed by an Israeli startup was implanted in the eye of a patient, enabling him to recognize his family and read words.

Amid ramped up production of vaccines, CARES Act gives FDA power to head off potential drug shortfalls. Prevent Blindness is urging the FDA to use its authority to ensure TED treatment drug supply isn’t interrupted.

From patient care and treating glaucoma to the ongoing pandemic, ophthalmologists share the most pressing thoughts of concern leaving them awake at night.

In a letter to Health and Human Services Secretary Alex Azar, the American Hospital Association is urging the federal government to expedite the administration of COVID-19 vaccines.

Tamara R. Fountain, MD, will serve as president of the American Academy of Ophthalmology after being elected by the organization’s community of ophthalmologists during its recent virtual annual meeting.

The investigational RNA therapy is designed to address the underlying cause of Leber congenital amaurosis 10 due to a mutation in the CEP290 gene.

ViGeneron and Biogen this week have announced a global collaboration and licensing agreement in which the partners will develop and commercialize gene therapy products based on adeno-associated virus (AAV) vectors that treat inherited eye disease.

Roche’s faricimab is the focus of Yosemite and Rhine studies, which investigators say show it has the potential to offer lasting vision improvements for patients with diabetic macular edema.

A cluster of COVID-19 positive patients developed endophthalmitis, and investigators are searching for a link.

Thomas Samuelson, MD, speaks on the outcomes of a three-year trial analyzing the iStent inject trabecular micro-bypass + phaco versus phaco alone in patients with POAG.

The platform can autonomously diagnose vision defects and customize individual vision augmentation based on the user’s vision defects.

Approval of the Moderna vaccine gives the US a second option in the fight against COVID-19.

Joshua Mali, MD, speaks on his annual top 5 predictions in ophthalmology for what's to come in 2021.

Preeya Gupta, MD, discusses the results of a study evaluating the safety and efficacy of KPI-121 0.25% for the treatment of dry eye disease.

Frontline healthcare workers are among the first to receive the vaccine, and ophthalmologists and clinic staff could soon start receiving doses.

Robert Ang, MD, discusses highlights of his AAO 2020 presentation on a study analyzing the vIsual outcomes of a small-aperture IOL implantation in patients with a history of post-laser refractive surgery.

In an open letter released Wednesday, the American Medical Association (AMA), American Hospital Association and the American Nurses Association are urging healthcare workers to get vaccinated against COVID-19.

Richard Lehrer, MD, speaks on the highlights of a study analyzing the success of SLT after trabecular bypass stenting / phacoemulsification, presented during AAO 2020.

The effort is designed to empower patients, improve coordinated care, and reduce regulatory burdens.

Michael R. Robinson, MD, Allergan, discusses the results from a study analyzing an investigational ophthalmic solution for treatment of symptoms associated with presbyopia presented during the virtual AAO 2020 meeting.

Tanner Ferguson, MD, Cole Eye Institute, discusses findings from the study "Trabecular Micro-bypass Stent Implantation (iStent)" + Phacoemulsification in PXG: Six-Year Outcomes," during the virtual AAO 2020 meeting.

Daniel H. Chang, MD, speaks on the highlights of his presentation on "Violet Light-Filtering IOLs: Visual and Non-Visual Benefits," during the virtual AAO 2020 meeting.

The Association for Research in Vision and Ophthalmology announced the switch to a virtual format this week for its annual meeting, originally scheduled for May 2-6 in San Francisco.

John A. Hovanesian, MD, discusses the highlights of his presentation on a clinical study evaluating dexamethasone vs prednisolone acetate 1% in controlling postop pain/inflammation in sequential cataract surgery patients.

The Centers for Medicare and Medicaid Services has released its final physician fee schedule for 2021. Despite opposition from the American Academy of Ophthalmology, the schedule includes an overall cut of 6% to ophthalmology.

During his 24-year tenure as chair of the Wayne State University School of Medicine’s department of ophthalmology and director of the Kresge Eye Institute, Dr. Jampel oversaw the growth of the department.

Michael R. Robinson, MD, shares the highlights of the study "Single administration of intracameral bimatoprost implant 10 µg: IOP lowering and safety," presented during the virtual AAO 2020 meeting.

Ehsan Rahimy, MD, speaks on the highlights of a study he presented at this year's virtual AAO 2020 meeting that aimed to integrate an artificial intelligence screening system for managing diabetic retinopathy referrals in a primary care setting — with limited specialty support.

Davinder Grover, MD, MPH, speaks on the highlights of his presentation regarding outcomes of a 12-year study comparing ab externo vs ab interno xen gel stents in tertiary glaucoma practice.